Table 1.
Sensitivity analysis cutoff point in our exploratory study | ||||||||
Method | Cutoff | C-index | Sensitivity | Specificity | Low NLR, no. of dead (%) | High NLR, no. of dead (%) | HR; 95%CI, P value | |
Our study | Continuous | – | 0.535 | – | – | – | – | 1.07; 1.01 to 1.13, .019 |
Median | 2.6 | 0.539 | 54.0% | 53.6% | 97/232 (42%) | 114/231 (49%) | 1.31; 1.00 to 1.72, .048 | |
Maximum C-index∗ | 3.0 | 0.548 | 41.7% | 67.9% | 123/294 (42%) | 88/169 (52%) | 1.43; 1.09 to 1.89, .010 | |
Mean | 3.2 | 0.539 | 35.6% | 73.0% | 136/320 (43%) | 75/143 (52%) | 1.39; 1.05 to 1.84, .023 | |
High sensitivity | 1.6 | 0.510 | 80% | 16.7% | 40/80 (50%) | 171/383 (45%) | 0.89; 0.63 to 1.26, .519 | |
High specificity | 3.8 | 0.529 | 27% | 80% | 154/357 (43%) | 57/106 (53%) | 1.38; 1.02 to 1.87, .037 | |
Sensitivity analysis of cutoff point from previous report | ||||||||
Lin et al[11] | AuROC | 2.2 | 0.510 | 63.5% | 37.3% | 77/171 (45%) | 134/292 (46%) | 1.10; 0.83 to 1.45, .523 |
Lu et al[12] | AuROC | 2.3 | 0.517 | 61.1% | 41.67% | 82/187 (44%) | 129/276 (47%) | 1.15; 0.87 to 1.52, .325 |
Li et al[8] | AuROC | 2.5 | 0.532 | 55.5% | 50.4% | 94/221 (43%) | 117/242 (48%) | 1.26; 0.96 to 1.65, .094 |
Sun et al[6] | AuROC | 2.6 | 0.539 | 54.0% | 53.6% | 97/232 (42%) | 114/231 (49%) | 1.31; 1.00 to 1.72, .048 |
Jiang et al[4] | AuROC | 2.7 | 0.536 | 49.8% | 57.9% | 106/252 (42%) | 105/211 (50%) | 1.32; 1.01 to 1.73, .046 |
Liao et al[10] | Mean | 3.6 | 0.530 | 29.9% | 77.8% | 148/344 (43%) | 63/119 (53%) | 1.34; 1.00 to 1.80, .050 |
An et al[7] | AuROC | 3.7 | 0.528 | 28.4% | 56.2% | 152/352 (43%) | 590111 (53%) | 1.35; 1.00 to 1.83, .049 |
Chua et al[15] | Median | 3.0 | 0.548 | 41.7% | 67.9% | 123/294 (42%) | 88/169 (52%) | 1.43; 1.09 to 1.89, .010 |
P80th | 4.2 | 0.537 | 23.7% | 84.9% | 161/375 (43%) | 50/88 (57%) | 1.57; 1.14 to 2.15, .006 |
CI = confidence interval, C-index = concordance index, HR = hazard ratio, NLR = neutrophil-to-lymphocyte ratio, AuROC = area under the receiver operating characteristic curve.